Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease

Aimin Xu1, Paul M Vanhoutte

  • 1Department of Pharmacology and Pharmacy, the University of Hong Kong, Hong Kong.

Insights

Adipokines from adipose tissue significantly impact cardiovascular health. While most are proinflammatory, adiponectin offers protection, highlighting their role in obesity-related heart disease.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Metabolic Disease Research

Background:

  • Epicardial and perivascular adipose tissues secrete adipokines crucial for cardiovascular homeostasis.
  • Adipokines form the 'adipo-cardiovascular axis,' mediating communication between adipose tissue, heart, and vasculature.
  • Dysfunctional adipose tissue's altered adipokine production contributes to obesity-related cardiovascular disease.

Purpose of the Study:

  • To review the role of adipokines in the pathogenesis of cardiovascular disorders linked to obesity and diabetes.
  • To focus on adiponectin and adipocyte fatty acid-binding protein (A-FABP) as key adipokines in cardiovascular disease.
  • To highlight adipokines as potential prognostic biomarkers and therapeutic targets for cardiovascular disease.

Main Methods:

  • Review of existing literature on adipokines and cardiovascular disease.
  • Analysis of data from animal studies and clinical investigations.
  • Focus on the roles of adiponectin and A-FABP in cardiovascular pathology.

Main Results:

  • Most adipokines, such as tumor necrosis factor-α, resistin, A-FABP, and lipocalin-2, are proinflammatory and linked to cardiac and endothelial dysfunction.
  • Adiponectin exhibits protective, pleiotropic effects on the heart and blood vessels, counteracting cardiovascular disease.
  • Adiponectin and A-FABP are identified as significant prognostic biomarkers for cardiovascular disease.

Conclusions:

  • Adipokines play a dual role in cardiovascular health, with opposing effects from different types.
  • Adiponectin and A-FABP are particularly important in obesity-related cardiovascular disease, serving as biomarkers and therapeutic targets.
  • Understanding adipokine function is vital for developing strategies against obesity- and diabetes-associated cardiovascular disorders.

Related Concept Videos

Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...